PledPharma AB announced that Henrik Krook takes on the position as Vice President Commercial Operations at PledPharma. The appointment is complementing PledPharma's acquisition of Rare Thyroid Therapeutics (RTT). Henrik will join the company in December. Henrik has a broad experience from over 15 years in commercial leadership settings, including both big pharma and biotechs. He has direct experience in general management, business development, market access, marketing, sales, clinical trials and strategy formulation, including the orphan drug segment, with a track record of developing companies, organizations and assets to ensure continuous value creation. He has previously held different senior corporate and commercial advisory roles for biotech companies such as Affibody and senior managerial positions at e g Alexion, Novartis and Roche.